Temporary keratoprosthesis and primary corneal graft for ocular trauma: a systematic review and meta-analysis.

Temporary keratoprosthesis corneal graft ocular trauma vitrectomy

Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 13 06 2024
revised: 16 09 2024
accepted: 18 09 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 29 9 2024
Statut: aheadofprint

Résumé

When severe retinal and corneal injury occur together, a temporary keratoprosthesis (TKP) is often a last resort to allow posterior segment visualization to enable vitreoretinal surgery, followed by a penetrating keratoplasty (PKP) which can restore corneal clarity in a single operation. We aimed to assess visual outcomes following combined PKP and vitreoretinal surgery with the use of a TKP for cases of ocular trauma. A systematic literature review was performed following PRISMA guidelines (PROSPERO registration number: CRD42023423518). CENTRAL, MEDLINE, Embase, ISRCTN registry and ClinicalTrials.gov were searched from inception to 27 April 2023. Randomized and non-randomized studies assessing visual outcomes after combined vitreoretinal surgery and PKP with the use of a TKP after ocular trauma were eligible for inclusion. Outcomes included change in best corrected visual acuity, corneal graft survival and retinal reattachment at final follow up. Proportional meta-analysis was used to estimate the overall rate of the primary outcomes. Risk of bias for non-randomized studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklist for case series. A total of 19 studies met inclusion criteria reporting a total of 352 eyes. All studies were retrospective and non-randomized with follow up times ranging from 6 to 91 months, with at least 79% of outcomes reported after 6 months. After combined surgery the rate of corneal graft survival was 52% (95% CI 0.41-0.62; I Patients with severe injury affecting the anterior and posterior segments have very limited treatment options. This systematic review found that when combined vitreoretinal surgery and PKP with a TKP are performed, approximately half of corneal grafts survive, anatomically successful retinal reattachment is likely, and a similar proportion of patients benefit in terms of improved visual acuity, compared to their preoperative function. This systematic review of the available literature may help inform surgeons of the benefits of using a TKP for cases of ocular trauma.

Identifiants

pubmed: 39343336
pii: S0002-9394(24)00452-5
doi: 10.1016/j.ajo.2024.09.025
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Conflict of Interest None.

Auteurs

David McMaster (D)

Imperial College London, London, UK.

Sophia Halliday (S)

BRAVO VICTOR, London, UK.

James Bapty (J)

Portsmouth Hospitals University NHS Trust, Portsmouth, UK.

Scott F McClellan (SF)

Vision Center of Excellence, Research & Development Directorate (J-9), Defence Health Agency, MD, USA.

Sarah C Miller (SC)

Wilmer Eye Institute, Johns Hopkins University School of Medicine, MD, USA.

Grant A Justin (GA)

Uniformed Services University of the Health Sciences, MD, USA; Duke Eye Center, Duke University Hospitals, NC, USA.

Rupesh Agrawal (R)

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Singapore Eye Research Institute, Singapore; Lee Kong Chian School of Medicine, Singapore; Duke NUS Medical School, Singapore.

Annette K Hoskin (AK)

Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Lions Eye Institute, University of Western Australia, Perth, Australia.

Kara Cavuoto (K)

Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.

James Leong (J)

Sydney Eye Hospital, Sydney, New South Wales, Australia.

Andrés Rousselot Ascarza (AR)

Consultorios Oftalmológicos Benisek-Ascarza, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.

Fasika A Woreta (FA)

Uniformed Services University of the Health Sciences, MD, USA.

John Cason (J)

Uniformed Services University of the Health Sciences, MD, USA.

Kyle E Miller (KE)

Uniformed Services University of the Health Sciences, MD, USA; Department of Ophthalmology, Navy Medical Center Portsmouth, VA, USA.

Matthew C Caldwell (MC)

Department of Ophthalmology, San Antonio Uniformed Services Health Education Consortium, TX, USA.

William G Gensheimer (WG)

White River Junction Veterans Administration Medical Center, White River Junction, VT, USA; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

Tom H Williamson (TH)

Department of Engineering and Biological Sciences, University of Surrey, Surrey, UK; Department of Ophthalmology, St Thomas' Hospital, London, UK.

Felipe Dhawahir-Scala (F)

Manchester Royal Eye Hospital, Manchester, UK.

Peter Shah (P)

Birmingham Institute for Glaucoma Research, Birmingham, UK; Ophthalmology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Andrew Coombes (A)

Department of Ophthalmology, The Royal London Hospital, London, UK.

Gangadhara Sundar (G)

Department of Ophthalmology, National University Hospital, Singapore.

Robert A Mazzoli (RA)

Uniformed Services University of the Health Sciences, MD, USA.

Malcolm Woodcock (M)

Worcestershire Acute Hospitals NHS Trust, Worcester, UK.

Stephanie L Watson (SL)

Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Sydney Eye Hospital, Sydney, New South Wales, Australia.

Ferenc Kuhn (F)

Helen Keller Foundation for Research and Education, AL, USA; Department of Ophthalmology, University of Pécs Medical School, Pécs, Hungary.

Marcus Colyer (M)

Uniformed Services University of the Health Sciences, MD, USA.

Renata Sm Gomes (RS)

BRAVO VICTOR, London, UK; Northern Hub for Veterans and Military Families Research, Northumbria University, Newcastle, UK.

Richard J Blanch (RJ)

Ophthalmology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, UK; Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. Electronic address: r.j.blanch@bham.ac.uk.

Classifications MeSH